NEWS
Institute Fellow appointed Deputy Lieutenant of Greater London
Institute Fellow Dr Mustafa A Abu-Lisan has been appointed Deputy Lieutenant of Greater London in the Royal Borough of Kensington & Chelsea. Dr Abu-Lisan was appointed to the post by Her Majesty’s Lord Lieutenant of Greater London, Kenneth Olisa. The Lord Lieutenant is an honorary
appointment, and acts as the Queen’s personal representative in Greater London. Dr Abu-Lisan said he is “honoured, delighted and privileged” to take up the position. Dr Abu-Lisan has had a distinguished
career as a clinical chemist spanning over 39 years. From Loughborough University, Derbyshire Royal Infirmary and the Queen’s Medical Centre in Nottingham, Dr Abu-Lisan then spent some time as a consultant clinical biochemist in Malta in the 1970s, before moving to the Ministry of Public Health in Kuwait in 1981. Dr Abu-Lisan was a founding chair of the
Kuwait group of clinical biochemists and later elected general secretary of the Arab Federation of Clinical Chemists, and vice- president of the Arab Federation of Clinical Biologists. In 1986 he was awarded the International Fellowship from the AACC for
of his time to bringing communities together and helping them take pride in their national identity and celebrate our multi-race, multi- faith and multi-culture society. Dr Abu-Lisan said: “There is a lot that
Dr Mustafa Abu-Lisan (left) with the Lord Lieutenant Mr Kenneth Olisa.
promoting the profession of clinical chemistry internationally and became a member of the World Health Organization (WHO) expert panel on the rational use of antibiotics for the Eastern Mediterranean Region. The Deputy Lieutenants of London are
distinguished residents who either have served the local community, or have a history of service in other fields. Dr Abu-Lisan has spent many years working with the community in his local borough of Kensington & Chelsea, and is looking forward to continuing this work. He dedicates much
needs to be done, can be done and must be done, to bridge the gap between the rich and the poor, if not financially at least socially, by identifying, recognising and rewarding those who have done a lot for the society but still feel isolated, excluded, ignored or marginalised. We are a multi-faith, multi-race and multi-culture society and we must work hard to make it a more tolerant, more inclusive and fairer society.” Deputy Lieutenants are expected to
continue to serve the community both within and outside the framework of the Lieutenancy. Dr Abu-Lisan feels that this appointment will help him to continue to endeavour to “help the long-term unemployed, the disadvantaged, the disabled and the disillusioned”. The Institute is delighted to congratulate
Dr Abu-Lisan on this prestigious appointment, and wish him all the best as he continues his excellent work.
Routes to registration approved by the HCPC
The Institute has been successfully audited by the Health and Care Professions Council (HCPC) and re-approved for the following routes to registration: • Certificate of Competence (accredited degree containing the Registration Training Portfolio): including sandwich degrees, 32 universities offer this option with a Biomedical Science degree, with only seven offering HCS degrees.
• Certificate of Competence (accredited
degree followed by the Registration Training Portfolio): 51 universities offer accredited degrees.
• Certificate of Competence (Non - accredited degree followed by the Registration Training Portfolio).
In total the IBMS now issues 700–800 Certificates of Competence annually. The Certificate of Competence by Equivalence (Biomedical Scientist) was not part of the audit
Non-gynaecological cytology role
The Institute has issued joint guidance outlining the role of biomedical scientists within the provision of non-gynaecological cytology services. The statement, issued jointly with The Royal College of Pathologists (RCPath) and British Association for Cytopathology (BAC), addresses changes in the non-gynaecological cytology service model. The updated guidance addresses areas
including; • sample preparation • reporting
THE BIOMEDICAL SCIENTIST MAY 2016
• ancillary testing • sample assessment for adequacy for reporting
• multidisciplinary team meetings • clinical scientists in cytology • continuing education, assessment and appraisal.
Additional IBMS guidance and policies can be found in the Professional Guidance pages via the link below.
www.ibms.org/go/media/publications/ professional-guidance
process and continues with its approval. The IBMS Certificate of Competence is a
professional qualification that demonstrates that the holder meets HCPC Standards of Proficiency, enabling them to apply for HCPC registration. More information about HCPC
registration can be found on the IBMS and HCPC websites.
www.ibms.org www.hcpc-uk.org
Influenza update
A new tobacco-based seasonal influenza vaccine currently is in phase III trials and could rival traditional egg-based vaccines by the 2018-19 influenza season. Tobacco-based vaccines are part of an emerging vaccine class that can generate effective and longer-lasting protection while being amenable to various production methods. The technology involved in the new vaccine, which can be produced in four weeks, six times faster than egg-based methods, involves implanting influenza genetic material into tobacco leaves.
229
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
